Solvias

Solvias, established in 1999, is a leading contract research, development, and manufacturing organization (CRDMO) serving pharmaceuticals, biotechnology, ATMP, medical devices, and cosmetics. Headquartered near Basel, Switzerland, the company leverages its extensive infrastructure and deep scientific expertise to deliver innovative solutions meeting the highest quality standards. Solvias specializes in developing, analyzing, and testing a broad spectrum of biological and chemical substances and products, acting as a key partner for clients aiming to accelerate product pipelines.

Employing 500-1,000 employees across 5 locations, Solvias is committed to understanding and fulfilling complex customer needs through collaborative efforts. Its highly qualified team members are integral to its success, driving its mission of providing integrated services. Meet Solvias's team to understand the expertise powering their operations. This focus on human capital, alongside robust operational capabilities, enables Solvias to manage intricate projects from early research through to manufacturing.

Solvias provides a comprehensive suite of services, including advanced analytical testing, custom synthesis, and proprietary catalysis technology. Their proprietary ligand portfolio is among the largest for catalytic transformations, highlighting their chemical innovation leadership. By offering integrated services, products, and technologies, Solvias helps customers bring safer, more effective products to market faster. Expertise covers CMC testing, biosafety, particle characterization, and quality control, ensuring rigorous scientific validation and regulatory compliance for diverse projects.